-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Kazia Therapeutics with Buy Rating, Announces Price Target of $34

Benzinga·07/01/2026 11:36:11
Listen to the news
BTIG analyst Kambiz Yazdi initiates coverage on Kazia Therapeutics (NASDAQ:KZIA) with a Buy rating and announces Price Target of $34.